4Wu GY, Zhu WB, Gao YX, et al. The risk factors of hand - foot - mouth disease in Chinese mainland people[J]. The Indian Journal of Pediatrics, 2014,81(12): 1 420 - 1 429.
5Lee MS, Tseng FC, Wang JR, et al. Challenges to licensure of enterovirus 71 vaccines[J]. PLoS One,2012,6(8): el 737.
6Tan X J, Huang XY, Zhu SL, et al. The persistent circulation of enterovirus71 in People's Republic of China: causing emerging nationwide epidemics since 2008 [ J ]. PLoS One, 2011,6 (9) : e25 662.
7Lee JJ, Seah JB, Chow VT, et al. Comparative proteome analyses of host protein expression in response to Enterovirus 71 and Coxsackievirus A16 infections[J]. Proteomics,201 1,74(10) : 2 018 - 2 024.
8Wu D, Ke Changwen, Li W, et al. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009[J] . Archives of virology, 2011,156 (6) : 945 - 953.
9Weng TY, Chen LC, Shu HW, et al. Lactoferrin inhibits enterovirus 7 ! in- fection by binding to VP1 protein and host cells [J ]. AntiviralRes, 2005, 67(1): 31 -37.
10Wang SM, Lei HY, Huang MC, et al. Therapeutic efficacy of milrinone in the management of enterovirus 71 - induced pulmonary edema[J ]. Pediatric Pulmonol, 2005,39 (3) : 219 - 223.
4Morris SJ, Bahizs H, Robert DG, et al. New adenovirus species found in a patient presenting with gastroenteritis. J Virol, 2007, p. 5978-5984. doi: 10.1128/JVI. 02650-06.
5Nguyen LT, Bui TS, Le HS, et al. Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malariadisease severity in Gabonese patients. BMC Infect Dis, 2013, 13 : 543-555. doi: 10. 1186/1471-2334-13-375.
